Page 19 - Vaccine

For a Covid-19 vaccine, journey from lab to jab can take up to 4 months

Manufacturing alone takes 40-120 days

Working to import Pfizer Covid-19 vaccine at the earliest, says govt

Pfizer's indemnity request is also being looked into by the government

Shortage of transparency

Govt, companies must end opacity on vaccine supplies

Cyprus health authority says people under 50 should use mRNA-based vaccines

Cypriot health authorities on Wednesday advised people aged under 50 to use the Pfizer/BioNTech or Moderna vaccines that are based on the newer, mRNA technology

India administers over 200 mn Covid-19 vaccine doses till May 25

In a landmark achievement in its fight against Covid-19, India has cumulatively administered more than 200 million vaccine doses up till 7 pm on May 25

GST panel rejects demand for tax waiver on Covid-19 vax, ventilator

GST fitment panel has recommended a short-term rate cut on four Covid-19 related items

AstraZeneca Pharma India Q4 net profit up nearly 3-fold to Rs 27.27 cr

Drug firm AstraZeneca Pharma India on Tuesday reported a nearly three-fold jump in its net profit to Rs 27.27 crore for the quarter ended March 31, 2021. The company had posted a net profit of Rs 9.57 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a regulatory filing. Revenue from operations of the company stood at Rs 210.25 crore for the quarter under consideration. It was Rs 194.90 crore for the same period a year ago, it added. For the financial year ended March this year, the net profit of the company was Rs 93.30 crore as against Rs 72.22 crore for the previous financial year, the filing said. The company's revenue from operations stood at Rs 813.56 crore for the financial year ended March 31, 2021. It was Rs 831.80 crore for the year-ago fiscal, it added. Shares of AstraZeneca Pharma India closed at Rs 3,862.45 per scrip on BSE, up 0.84 percent from its previous close.

Delhi yet to receive more Covid-19 vaccines for 18-44 group, says Atishi

Delhi is yet to receive more vaccines for the 18-44 age group and only private hospitals are giving jabs to beneficiaries in this category for now, Aam Aadmi Party MLA Atishi said on Tuesday

Oh for a simpler world?

Well, never underestimate this country and how badly or well something may be managed unless you experience it for yourself

Covid vaccination: Walk-ins allowed for 18-44 age bracket at govt centres

Private centres have to continue publishing their vaccination schedule in advance for online appo­in­tments

Centre steps in after foreign Covid-19 vaccine makers say no to state govts

Union govt in direct talks with firms but order book full for now

Top headlines: Grasim Q4 net rises 13%; BSE sees a new milestone

Business Standard brings you the top news of the evening

Covid-19 crisis: Punjab says Moderna refused to send vaccines directly

The world's largest vaccine-producing nation has fully vaccinated a little more than 41.6 million people, or only 3.8 per cent of its 1.35 billion population

G20 leaders vow unity; to boost vaccine access to fight Covid-19 pandemic

To sign 'Declaration of Rome'- guiding principles that prioritise multilateralism

Inheritance of ideas

In the midst of a raging debate over IP rights, the million-dollar question is who owns the vaccine? Is it the pharma firms, the country origin, the university they are developed in or the people?

The confidence that proved disastrous

The government has been inept in all that was required of it

I didn't 'destroy' India's self-sufficiency in vaccine production: Ramadoss

The Union health minister in the first term of the UPA government, Anbumani Ramadoss clarifies he did not close down govt-run vaccine manufacturing units

Daily Covid-19 cases below 300k after a 26-day run: Health ministry

Cases still rising in many parts; 20% plus positivity in 244 districts

Pharma sector's Q4 results show moderate gains amid Covid-19 pandemic

The ongoing April-June quarter should see strong growth due to low base of last year

The way forward for firms

Indian firms need to prepare for export boom by vaccinating employees, their family members; and prioritise export market